These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

865 related items for PubMed ID: 6135396

  • 1. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M, Hashimoto H, Nakashima M.
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [Abstract] [Full Text] [Related]

  • 2. Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133).
    Honda K, Takenaka T, Miyata-Osawa A, Terai M.
    J Pharmacol Exp Ther; 1986 Mar; 236(3):776-83. PubMed ID: 2869143
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro.
    Perrone MH, Hamel LT, Ferrari RA, Haubrich DR.
    J Pharmacol Exp Ther; 1990 Aug; 254(2):471-5. PubMed ID: 1974637
    [Abstract] [Full Text] [Related]

  • 5. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
    Van Inwegen RG, Khandwala A, Weinryb I, Pruss TP, Neiss E, Sutherland CA.
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
    [Abstract] [Full Text] [Related]

  • 6. Alpha-1 adrenoceptors in human prostate: characterization and alteration in benign prostatic hypertrophy.
    Yamada S, Ashizawa N, Ushijima H, Nakayama K, Hayashi E, Honda K.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):326-30. PubMed ID: 2441028
    [Abstract] [Full Text] [Related]

  • 7. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
    Miyagishi A, Nakahara H, Hara Y.
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL, Leslie FM.
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1092-8. PubMed ID: 2885406
    [Abstract] [Full Text] [Related]

  • 9. Selectivity of benzodioxane alpha-adrenoceptor antagonists for alpha 1- and alpha 2-adrenoceptors determined by binding affinity.
    Timmermans PB, van Kemenade JE, Batink HD, van Zwieten PA.
    Pharmacology; 1983 Jun; 26(5):258-69. PubMed ID: 6134295
    [Abstract] [Full Text] [Related]

  • 10. Alpha-2 adrenoreceptors on arterial smooth muscle: selective labeling by [3H]clonidine.
    Weiss RJ, Webb RC, Smith CB.
    J Pharmacol Exp Ther; 1983 Jun; 225(3):599-605. PubMed ID: 6134815
    [Abstract] [Full Text] [Related]

  • 11. 3H-Prazosin binds specifically to 'alpha 1'-adrenoceptors in rat brain.
    Miach PJ, Dausse JP, Cardot A, Meyer P.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 May; 312(1):23-6. PubMed ID: 6248797
    [Abstract] [Full Text] [Related]

  • 12. Displacement by alpha-adrenergic agonists and antagonists of 3H-prazosin bound to the alpha-adrenoceptors of the dog aorta and the rat brain.
    Nagatoma T, Tsuchihashi H, Sasaki S, Nakagawa Y, Nakahara H, Imai S.
    Jpn J Pharmacol; 1985 Feb; 37(2):181-7. PubMed ID: 2860265
    [Abstract] [Full Text] [Related]

  • 13. Alpha 1-adrenoceptors in guinea-pig heart ventricles. [3H]prazosin and [125I]IBE 2254 are bound specifically to a receptor population with high affinity and low density.
    Rugevics CU, Schümann HJ.
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):234-50. PubMed ID: 2827596
    [Abstract] [Full Text] [Related]

  • 14. Alpha 1 and alpha 2 Adrenergic receptors in mouse brain astrocytes from primary cultures.
    Ebersolt C, Perez M, Bockaert J.
    J Neurosci Res; 1981 Oct; 6(5):643-52. PubMed ID: 6119369
    [Abstract] [Full Text] [Related]

  • 15. Adrenergic receptors in human liver plasma membranes: predominance of beta 2- and alpha 1-receptor subtypes.
    Kawai Y, Powell A, Arinze IJ.
    J Clin Endocrinol Metab; 1986 May; 62(5):827-32. PubMed ID: 3007555
    [Abstract] [Full Text] [Related]

  • 16. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A, Olmos G, Sastre M, Barturen F, Martin I, Garcia-Sevilla JA.
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
    [Abstract] [Full Text] [Related]

  • 17. Agonists interaction with radiolabeled alpha-adrenoceptor antagonists binding sites in rat mesenteric artery.
    Agrawal DK, Daniel EE.
    J Cardiovasc Pharmacol; 1985 Mar; 7 Suppl 6():S66-75. PubMed ID: 2414598
    [Abstract] [Full Text] [Related]

  • 18. In vivo identification and distribution of alpha- and beta-adrenoceptors in rat heart and lung.
    Barnes PJ, Karliner JS.
    Pharmacology; 1982 Mar; 24(6):321-7. PubMed ID: 6287506
    [Abstract] [Full Text] [Related]

  • 19. Specific binding of 3H-guanfacine to alpha 2-adrenoceptors in rat brain. Comparison with 3H-clonidine.
    Dausse JP, Cardot A, Meyer P.
    J Pharmacol; 1983 Mar; 14(1):35-46. PubMed ID: 6300560
    [Abstract] [Full Text] [Related]

  • 20. Increased affinity and preference of halogenated derivatives of BE 2254 for alpha 1-adrenoceptors demonstrated by functional and binding experiments.
    Schlicker E, Brodde OE, Göthert M, Schaperdoth M.
    J Cardiovasc Pharmacol; 1984 Mar; 6(6):1238-44. PubMed ID: 6084785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.